document.getElementById('FCDPublications').innerHTML='

Gumm AJ, Chan AY, Margolis DA, Gries M, Lerret S.  Liver Transplant Associated Systemic Graft-Versus-Host Disease Following Complete Donor Hematopoietic Chimerism.  Prog Transplant.   2021 Dec;31(4):392-393 PMID: 34713736 SCOPUS ID: 2-s2.0-85118239632 10/30/2021

Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, Bunin NJ.  Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy.  Biol Blood Marrow Transplant.   2020 Mar;26(3):493-501 PMID: 31765697 SCOPUS ID: 2-s2.0-85077542518 11/26/2019

Liberio N, Robinson H, Nugent M, Simpson P, Margolis DA, Malarkannan S, Keever-Taylor C, Thakar MS.  Single-center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia.  Pediatr Blood Cancer.   2019 Nov;66(11):e27950 PMID: 31368194 PMCID: PMC6754268 SCOPUS ID: 2-s2.0-85070087706 08/02/2019

Becktell K, Berlyne D, Pagliuca S, Pommert L, Prata PH, Margolis D, de Latour RP, Dufour C, Pierri F.  Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.  Leuk Res.   2019 May;80:19-25 PMID: 30908982 SCOPUS ID: 2-s2.0-85063209621 03/26/2019

Hoogenboom L, Margolis D, Anderson L, Phelan R.  Sequential transplantation and implications for clinical management: OLT followed by HCT and consequent RT in a pediatric patient.  Pediatr Transplant.   2019 May;23(3):e13370 PMID: 30779289 SCOPUS ID: 2-s2.0-85061909142 02/20/2019

Broglie L, Margolis D, Medin JA.  Yin and Yang of mesenchymal stem cells and aplastic anemia.  World J Stem Cells.   2017 Dec 26;9(12):219-226 PMID: 29321823 PMCID: PMC5746642 SCOPUS ID: 2-s2.0-85041751810 01/13/2018

Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J.  Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.  Blood Adv.   2017 Aug 22;1(19):1533-1536 PMID: 29296794 PMCID: PMC5728466 SCOPUS ID: 2-s2.0-85040141428 01/04/2018

Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, Frangoul H, Margolis DA, Baker KS, Nemecek ER, Geddis AE, Sandmaier BM, Deeg HJ, Storb R, Woolfrey AE.  Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.  Biol Blood Marrow Transplant.   2017 Oct;23(10):1669-1677 PMID: 28602958 PMCID: PMC5605451 SCOPUS ID: 2-s2.0-85025429864 06/13/2017

Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, Patel P, Gould E, Rinehart AR, Smith KY, Spreen WR.  Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.  Lancet HIV.   2017 Aug;4(8):e331-e340 PMID: 28546090 05/27/2017

Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ.  Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).  Biol Blood Marrow Transplant.   2017 Aug;23(8):1320-1326 PMID: 28411175 PMCID: PMC5518678 SCOPUS ID: 2-s2.0-85019572284 04/16/2017


Publications of David A. Margolis MD from the Faculty Collaboration Database'